Upregulation of serum miR-4429 discriminates chronic heart failure patients and regulates cardiomyocyte injury via modulating HAPLN1
The upregulation of miR-4429 served as a biomarker discriminating CHF patients and indicating severe disease conditions. Silencing miR-4429 could alleviate cardiomyocyte injury via negatively regulating HAPLN1.
Authors
- Yiming Yu (ORCID: https://orcid.org/0000-0002-9919-7282)
- Feng Li (ORCID: https://orcid.org/0000-0001-5868-7456)
- Jingjing Wu (ORCID: https://orcid.org/0000-0002-5046-9996)
- Ge Xiao
- He Sun
- Lifang Cao (ORCID: https://orcid.org/0000-0001-7424-8656)
Institutions
- Heilongjiang University of Chinese Medicine (CN)
- Weifang People's Hospital (CN)
- Pudong New Area People's Hospital (CN)
Publication Details
- Journal
- Minerva Cardiology and Angiology
- Published
- 2024-09-16
- DOI
- https://doi.org/10.23736/s2724-5683.24.06596-7
- Primary Topic
- Signaling Pathways in Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00